Carotid hemodynamics is associated with monocyte count determined by serum homocysteine level in patients with essential hypertension

References

• Mudd SH, Finkelstein JD, Refsum H, et al. Homocysteine and its disulfide derivatives: a suggested consensus terminology. Arterioscler Thromb Vasc Biol 2000;20:1704–6
   PubMed Web of Science ®Google Scholar
• Nyfard O, Nordrehaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230–6
   PubMed Web of Science ®Google Scholar
• Soinio M, Marniemi J, Laakso M, et al. Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus. Ann Intern Med 2004;140:94–100
   PubMed Web of Science ®Google Scholar
• Cheng SW, Ting AC, Wong J. Fasting total plasma homocysteine and atherosclerotic peripheral vascular disease. Ann Vasc Surg 1997;11:217–23
   PubMed Web of Science ®Google Scholar
• Perry IJ, Refsum H, Morris RW, et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346:1395–8
   PubMed Web of Science ®Google Scholar
• Towfighi A, Saver JL, Engelhardt R, Ovbiagele B. Factors associated with the steep increase in late-midlife stroke occurrence among US men. J Stroke Cerebrovasc Dis 2008;17:165–8
   PubMedGoogle Scholar
• Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004;291:565–75
   PubMed Web of Science ®Google Scholar
• Lonn E, Yusuf S, Arnold MJ, et al. Heart outcomes Prevention Evaluation (HOPE) 2 Investigators: homocysteine lowering with folic acid and B vitamins in vascular disease. N Eng J Med 2006;354:1567–77
   PubMed Web of Science ®Google Scholar
• Bønaa KH, Njølstad I, Ueland PM, et al.; NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Eng J Med 2006;354:1578–88
   PubMed Web of Science ®Google Scholar
• van Dijk SC, Smulders YM, Enneman AW, et al. Homocysteine level is associated with aortic stiffness in elderly: cross-sectional results from the B-PROOF study. J Hypertens 2013;31:952–9
   PubMed Web of Science ®Google Scholar
• Lim MH, Cho YI, Jeong SK. Homocysteine and pulsatility index of cerebral arteries. Stroke 2009;40:3216–20
   PubMed Web of Science ®Google Scholar
• Xiao W, Bai Y, Ye P, et al. The differences in homocysteine level between obstructive sleep apnea patients and controls: a meta-analysis. PLoS One 2014;9:e95794
   PubMedGoogle Scholar
• Okura T, Miyoshi K, Irita J, et al. Hyperhomocysteinemia is one of the risk factors associated with cerebrovascular stiffness in hypertensive patients, especially elderly males. Sci Rep 2014;4:5663
   PubMed Web of Science ®Google Scholar
• Sabatine MS, Morrow DA, Cannon CP, et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial) substudy. J Am Coll Cardiol 2002;40:1761–8
   PubMed Web of Science ®Google Scholar
• Margolis KL, Manson JE, Greenland P, et al.; Women's Health Initiative Research Group. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med 2005;165:500–8
   PubMed Web of Science ®Google Scholar
• Brown DW, Giles WH, Croft JB. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol 2001;54:316–22
   PubMed Web of Science ®Google Scholar
• Naruko T, Ueda M, Haze K, et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002;106:2894–900
   PubMed Web of Science ®Google Scholar
• Tavora F, Kutys R, Li L, et al. Adventitial lymphocytic inflammation in human coronary arteries with intimal atherosclerosis. Cardiovasc Pathol 2010;19:e61–8
   PubMedGoogle Scholar
• Maffia P, Zinselmeyer BH, Ialenti A, et al. Images in cardiovascular medicine. Multiphoton microscopy for 3-dimensional imaging of lymphocyte recruitment into apolipoprotein-E-deficient mouse carotid artery. Circulation 2007;115:e326–8
   Web of Science ®Google Scholar
• Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989;135:169–75
   PubMed Web of Science ®Google Scholar
• Berg KE, Ljungcrantz I, Andersson L, et al. Elevated CD14++CD16- monocytes predict cardiovascular events. Circ Cardiovasc Genet 2012;5:122–31
   PubMed Web of Science ®Google Scholar
• Rogacev KS, Ulrich C, Blömer L, et al. Monocyte heterogeneity in obesity and subclinical atherosclerosis. Eur Heart J 2010;31:369–76
   PubMed Web of Science ®Google Scholar
• Cardoso CR, Marques CE, Leite NC, Salles GF. Factors associated with carotid intima-media thickness and carotid plaques in type 2 diabetic patients. J Hypertens 2012;30:940–7
   PubMed Web of Science ®Google Scholar
• Simon A, Gariepy J, Chironi G, et al. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002;20:159–69
   PubMed Web of Science ®Google Scholar
• Ozari HO, Oktenli C, Celik S, et al. Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? J Clin Ultrasound 2012;40:335–40
   PubMed Web of Science ®Google Scholar
• Nakatou T, Nakata K, Nakamura A, Itoshima T. Carotid haemodynamic parameters as risk factors for cerebral infarction in Type 2 diabetic patients. Diabet Med 2004;21:223–9
   PubMed Web of Science ®Google Scholar
• Staub D, Meyerhans A, Bundi B, et al. Prediction of cardiovascular morbidity and mortality: comparison of the internal carotid artery resistive index with the common carotid artery intima-media. Stroke 2006;37:800–5
   PubMed Web of Science ®Google Scholar
• Kurata M, Okura T, Watanabe S, Higaki J. Association between carotid hemodynamics and asymptomatic white and gray matter lesions in patients with essential hypertension. Hypertens Res 2005;28:797–803
   PubMed Web of Science ®Google Scholar
• Zhang D, Fang P, Jiang X, et al. Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr/CBS-deficient mice. Circ Res 2012;111:37–49
   PubMed Web of Science ®Google Scholar
• Zhang D, Jiang X, Fang P, et al. Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice. Circulation 2009;120:1893–902
   PubMed Web of Science ®Google Scholar
• Manabe S, Okura T, Watanabe S, Higaki J. Association between carotid haemodynamics and inflammation in patients with essential hypertension. J Hum Hypertens 2005;19:787–91
   PubMed Web of Science ®Google Scholar
• Matsuo S, Imai E, Horio M, et al. Collaborators developing the Japanese equation for estimated GFR: revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982–92
   PubMed Web of Science ®Google Scholar
• Nozawa N, Hibi K, Endo M, et al. Association between circulating monocytes and coronary plaque progression in patients with acute myocardial infarction. Circ J 2010;74:1384–91
   PubMed Web of Science ®Google Scholar
• Fukuda D, Shimada K, Tanaka A, et al. Circulating monocytes and in-stent neointima after coronary stent implantation. J Am Coll Cardiol 2004;43:18–23
   PubMed Web of Science ®Google Scholar
• Nasir K, Guallar E, Navas-Acien A, et al. Relationship of monocyte count and peripheral arterial disease: results from the National Health and Nutrition Examination Survey 1999-2002. Arterioscler Thromb Vasc Biol 2005;25:1966–71
   PubMed Web of Science ®Google Scholar
• Da Cunha AA, Ferreira AG, Wyse AT. Increased inflammatory markers in brain and blood of rats subjected to acute homocysteine administration. Metab Brain Dis 2010;25:199–206
   PubMed Web of Science ®Google Scholar
• Liao D, Tan H, Hui R, et al. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance. Circ Res 2006;99:598–606
   PubMed Web of Science ®Google Scholar
• Mikael LG, Genest J Jr, Rozen R. Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease. Circ Res 2006;98:564–71
   PubMed Web of Science ®Google Scholar
• Lubomirova M, Tzoncheva A, Petrova J, Kiperova B. Homocystein and carotid atherosclerosis in chronic renal failure. Hippokratia 2007;11:205–9
   PubMedGoogle Scholar
• Goessens BM, van der Graaf Y, Olijhoek JK, Visseren FL. SMART Study Group: the course of vascular risk factors and the occurrence of vascular events in patients with symptomatic peripheral arterial disease. J Vasc Surg 2007;45:47–54
   PubMed Web of Science ®Google Scholar
• Dietrich M, Jacques PF, Polak JF, et al. Segment-specific association between plasma homocysteine level and carotid artery intima-media thickness in the Framingham Offspring Study. J Stroke Cerebrovasc Dis 2011;20:155–61
   PubMed Web of Science ®Google Scholar
• Ham AC, Enneman AW, van Dijk SC, et al. Associations between medication use and homocysteine levels in an older population, and potential mediation by vitamin B12 and folate: data from the B-PROOF Study. Drugs Aging 2014;31:611–21
   PubMed Web of Science ®Google Scholar